Weekly Investment Analysts’ Ratings Updates for Transcat (TRNS)

Several brokerages have updated their recommendations and price targets on shares of Transcat (NASDAQ: TRNS) in the last few weeks:

  • 5/22/2024 – Transcat had its price target raised by analysts at Oppenheimer Holdings Inc. from $125.00 to $160.00. They now have an “outperform” rating on the stock.
  • 5/22/2024 – Transcat was downgraded by analysts at Northland Securities from an “outperform” rating to a “market perform” rating.
  • 5/22/2024 – Transcat was downgraded by analysts at Northland Capmk from a “strong-buy” rating to a “hold” rating.
  • 5/22/2024 – Transcat had its price target raised by analysts at HC Wainwright from $124.00 to $156.00. They now have a “buy” rating on the stock.
  • 4/18/2024 – Transcat had its “outperform” rating reaffirmed by analysts at Oppenheimer Holdings Inc.. They now have a $125.00 price target on the stock, up previously from $120.00.
  • 4/16/2024 – Transcat had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $124.00 price target on the stock.

Transcat Stock Performance

NASDAQ TRNS opened at $127.40 on Monday. The company has a quick ratio of 2.62, a current ratio of 3.14 and a debt-to-equity ratio of 0.01. Transcat, Inc. has a 52-week low of $81.26 and a 52-week high of $147.00. The business’s 50-day moving average price is $115.94 and its 200 day moving average price is $108.12. The firm has a market cap of $1.16 billion, a P/E ratio of 80.13 and a beta of 0.68.

Insider Buying and Selling

In related news, CEO Lee D. Rudow sold 12,000 shares of the firm’s stock in a transaction dated Thursday, May 23rd. The stock was sold at an average price of $135.10, for a total transaction of $1,621,200.00. Following the transaction, the chief executive officer now owns 91,692 shares of the company’s stock, valued at $12,387,589.20. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In related news, CEO Lee D. Rudow sold 12,000 shares of the firm’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $135.10, for a total value of $1,621,200.00. Following the completion of the sale, the chief executive officer now owns 91,692 shares in the company, valued at $12,387,589.20. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Lee D. Rudow sold 3,343 shares of the firm’s stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $124.12, for a total transaction of $414,933.16. Following the completion of the sale, the chief executive officer now owns 103,692 shares of the company’s stock, valued at approximately $12,870,251.04. The disclosure for this sale can be found here. Insiders have sold a total of 23,230 shares of company stock valued at $3,056,967 over the last quarter. 4.20% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Transcat

A number of hedge funds have recently added to or reduced their stakes in TRNS. State Board of Administration of Florida Retirement System acquired a new stake in shares of Transcat during the 3rd quarter valued at approximately $207,000. Arizona State Retirement System acquired a new stake in shares of Transcat during the 3rd quarter valued at approximately $213,000. Virtu Financial LLC acquired a new stake in shares of Transcat during the 1st quarter valued at approximately $224,000. Quantbot Technologies LP lifted its position in shares of Transcat by 118.2% during the 3rd quarter. Quantbot Technologies LP now owns 2,370 shares of the scientific and technical instruments company’s stock valued at $232,000 after acquiring an additional 1,284 shares during the period. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of Transcat by 13.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,347 shares of the scientific and technical instruments company’s stock valued at $262,000 after acquiring an additional 284 shares during the period. Institutional investors and hedge funds own 98.34% of the company’s stock.

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

See Also

Receive News & Ratings for Transcat Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat Inc and related companies with MarketBeat.com's FREE daily email newsletter.